When you buy through links on our site , we may realize an affiliate commission . Here ’s how it work .
scientist have chance a new mark for a head disorderliness calledchronic traumatic brain disease ( CTE)that could help doctors diagnose the condition while a person is still alive , rather than after the person ’s dying , as was the shell for NFL histrion Aaron Hernandez .
CTE is a degenerative brain disease found in people with a history of repeated blows to the headland , includingpro - football playersand packer , according to the research worker , from the Boston University School of Medicine and the VA Boston Healthcare System . A previous study from the same group of researcher found CTE in 110 out of 111 former NFL musician . However , presently , the condition can be diagnosed only by examining a person ’s brain tissue paper after their death , so there is an " urgent want for a method to notice CTE during life , " the researchers articulate .
In the new subject , the researchers performed a post-mortem analysis of the mastermind of 23 former college and professional football histrion , 50 non - athlete withAlzheimer ’s disease(a mastermind disease with like symptoms to CTE ) and 18 non - athletes without Alzheimer ’s disease .
They found that the athletes with CTE had elevated levels of a protein called CCL11 in their brains , compare with the brains of the non - athletes with and without Alzheimer ’s disease .
In add-on , the researchers found that the more age an jock had play football game , the greater the levels of CCL11 were in their brain . [ 10 Things You Did n’t Know About the Brain ]
The researcher also want to see if that so - called biomarker for CTE would show up in a person ’s cerebrospinal fluid — something that can be sampled when a mortal is alive . They took postmortem examination samples of the cerebrospinal fluid from eight of the non - jock without CTE or Alzheimer ’s and seven of the jock with CTE . Again , they found that grade of CCL11 were elevated in the samples from players with CTE , compared with the non - athletes without CTE .
These finding propose that levels of CCL11 in the cerebrospinal fluid might be able to help name CTE during a person ’s life .
" The findings of this subject area are the early steps toward identifying CTE during life , " Dr. Ann McKee , theater director of Boston University ’s CTE Center and fourth-year writer of the subject field , said in a statement . " Once we can successfully diagnose CTE in living individuals , we will be much closer to discovering handling for those who suffer from it . "
However , more research is need to confirm the results using samples of cerebrospinal fluid from living multitude , and to settle whether increased levels of CCL11 are an early or previous occurrence in citizenry with CTE .
In addition , it ’s likely that multiple biomarkers , rather than just one , will be needed to definitively diagnose CTE in subsist masses , the researchers suppose .
The study is published today ( Sept. 26 ) in the journalPLOS ONE .
Original article onLive Science .
